NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)

43 filings reported holding NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) as of Q2 2024.
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 15.1M shares of 264M outstanding shares and own 5.73% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (6.91M shares), Caligan Partners LP (3.37M shares), BOOTHBAY FUND MANAGEMENT, LLC (1.38M shares), TWO SIGMA ADVISERS, LP (577K shares), Temasek Holdings (Private) Ltd (567K shares), TWO SIGMA INVESTMENTS, LP (478K shares), GSA CAPITAL PARTNERS LLP (272K shares), Exome Asset Management LLC (271K shares), BANK OF MONTREAL /CAN/ (245K shares), and EDBI Pte Ltd (222K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.